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Resumo 
Nesta tese apresenta-se uma prova de conceito de um processo de diafiltração 
para a purificação de ingredientes farmacêuticos ativos (APIs) integrando duas 
membranas de Nanofiltração por Solvente Orgânico (OSN). As soluções testadas 
incluíram PEG400, PEG1000, PEG2000, PEG8000 e PEG20000 em THF, pois os APIs 
têm um peso molecular (MW) de 8000Da e 20kDa, enquanto as impurezas e 
subprodutos variam até 2000Da.  
Numa fase inicial, PBIj1000, PBIm5j2005, PEEK50, PEEK80 e membranas de 
polietileno (PE) modificadas com 2g/L ou 4g/L de polidopamina por 18h, 30h e 48h foram 
testadas em single stage a diferentes pressões. Os resultados mostram que o PE 
revestido com 2g/L de polidopamina apresenta rejeições abaixo de 50% para PEG2000 
e acima de 85% para PEGs maiores, enquanto o PBIj1000 tem cerca de 78% de rejeição 
para PEG2000 e cerca de 98% para PEG8000 e PEG20000.  
Os processos de cascata e diafiltração foram simulados no MATLAB para 
entender as condições de pressão de cada estágio. A partir dos resultados em cascata, 
o mais adequado para realizar a diafiltração foi PDA2g/L_30h a 20bar no primeiro 
estágio e PBIj1000 a 10bar no segundo estágio. A rejeição no segundo estágio foi 95% 
para PEG8000 e PEG20000 e 68% para PEG2000. Na primeira configuração para 
diafiltração, embora a curva de pureza experimental se ajuste ao modelo, o rendimento 
experimental para PEG8000 e PEG20k caiu para 10% após 6 vols, enquanto as 
previsões apontaram para 90%. No entanto, depois da alteração da configuração da 
diafiltração, substituindo o agitador magnético por agitação por bombas, o rendimento 
do produto experimental aumentou de 10% para 30%, como consequência do aumento 
dos efeitos da transferência de massa. A pureza experimental do produto foi menor que 
anteriormente e 10% inferior aos valores previstos pela simulação, atingindo 50% e 60% 
para PEG8000 e PEG20k, respectivamente. 
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Abstract 
This thesis is a proof of concept of a diafiltration process for the purification of 
active pharmaceutical ingredients (APIs) integrating two Organic Solvent Nanofiltration 
(OSN) membranes for a more efficient separation. The solutions tested included 
PEG400, PEG1000, PEG2000, PEG8000 and PEG20000 in THF due to the fact that the 
target APIs products have a molecular weight (MW) of 8000Da and 20kDa while the 
impurities and by-products range 2000Da. 
In an initial phase PBIj1000, PBIm5j2005, PEEK50, PEEK80 and membranes 
based on polyethylene (PE) coating with 2g/L or 4g/L of polydopamine for 18h, 30, and 
48h different were tested in a single stage mode at different pressures. The results show 
that PE coated with 2g/L of polydopamine presents rejections below 50% for PEG2000 
and above 85% for larger PEGs, while PBIj1000 has about 78% rejection for PEG2000 
and about 98% for PEG8000 and PEG20000.  
It was necessary to simulate the cascade and diafiltration process in MATLAB in 
order to understand the pressure conditions for each stage. From the cascade results, 
the most suitable to perform diafiltration was PDA2g/L_30h at 20 bar in the first stage 
and PBIj1000 at 10 bar for the second stage, with the second stage rejecting about 95% 
PEG8000 and PEG20000, and 68% PEG2000. The first configuration for diafiltration, 
although the experimental purity curve fits the model prediction, the experimental yield 
for PEG8000 and PEG20k dropped to 10% after 6 vols while the predictions pointed to 
90%. Nevertheless, once the diafiltration configuration was changed, by replacing the 
magnetic stirrer for agitation by pumps, the experimental product yield increased from 
10% to 30%, as a consequence of an increase in mass transference effects. The 
experimental purity of the product was lower than previously and usually 10% lower than 
the simulation predictions reaching 50% and 60% for PEG8000 and PEG20k, 
respectively. 
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1 . Introduction and Scope of Thesis 
In the pharmaceutical industry, the separation and purification of active 
pharmaceutical ingredients (APIs) account for about 40-70% of the total capital cost of 
the process (Spear, 2006). Therefore improving the efficiency of the process is crucial to 
minimize the production costs without compromising the quality of the product and the 
regulations that have to be obeyed in order to be commercialized. In a synthesis, 
intermediate products and the APIs have to be separated from the by-products and 
unreacted reagents. Usually, this by-products and unreacted reagents have a smaller 
molecular weight (MW) but they can also have higher MW. Technologies such as 
crystallization and column chromatography are usually used in purification, but these are 
expensive and difficult to control (Silva, 2012). 
Organic Solvent Nanofiltration (OSN) is an emerging technology with the 
potential to separate different solutes based on their size and charge. This separation is 
achieved by the pressure difference across the membrane that retains the solute with 
higher MW and permeates the solute with smaller MW than the membrane pores. The 
advantage of this process compared with crystallization and column chromatography is 
that the energy consumption is lower and due to the fact that works at room temperature, 
thermal degradation and side reactions are avoided (Vandezande, 2008).  
A typical example of API synthesis is a fragment condensation process of 
peptides as performed in the solution phase. A new concept for this process is based on 
assembling fragments of amino acids to a soluble polymer. In every step of the synthesis, 
it is necessary to purify the growing peptide from excess fragments and reagents by 
diafiltration processes. For the purification process, it is essential that membranes with 
appropriate separation properties are utilised in order to maximize peptide yield and 
purity. 
Therefore, this thesis focuses on the selection of OSN membranes appropriate 
for the purification of peptide via fragment condensation. As a case study, it is selected 
synthesis of Glucagon via condensation of 4 fragments with MW of about 2000Da. 
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2 . Background and Literature Review 
In this chapter, it will be presented the state of art of the membrane technology 
relevant to understanding the research and data that were collected and analysed. 
2.1. Introduction to Membrane Technology 
A membrane is a physical barrier between two distinct solutions, which allow 
selectively that some components pass through it. There are different separation 
mechanism based on different physical principles. 
2.1.1 Nanofiltration and Organic Solvent Nanofiltration  
Membranes are selective semi-permeable barriers and in recent years have been 
studied and used in separation and purification processes. These barriers separate the 
solutes in permeate and retentate according to their molecular weight, Figure 1. There 
is no rule concerning the retentate being or not being the desired product, due to the fact 
that the desired product can be the one with higher MW and be in the retentate or the 
one with smaller MW and be the permeate. Depending on the range of MW they can 
separate, membranes can be classified as reverse osmosis, nanofiltration, ultrafiltration 
and microfiltration. In this work, the OSN requires a nanofiltration membrane. (Mulder, 
Ch I Introduction, 1996) (R.W., 2004) One of the most important parameters that 
characterize the operating conditions of a membrane is the molecular weight cut-off 
(MWCO). The MWCO is a parameter that describes the operating range of the 
membrane and it’s defined as the MW for which 90% of the solute is rejected by the 
membrane (See-Toh., 2008)  
 
 
Figure 1. Schematic diagram of the basic membrane gas separation process (adapted from 
(R.W., 2004) 
 
Nanofiltration (NF) was initially developed for water softening. Nowadays it’s a 
separation method based on the size and molecular weight (MW) for molecules ranging 
from 100-2000 Da. The solute with smaller MW will be rejected by the membrane and 
will form the permeate. In recent years NF has evolved to what today is called organic 
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solvent nanofiltration (OSN), an approach to perform separations in organic solvents at 
room temperature. In this membrane-based approach that operates in a range of 200-
1000 Da, the solute is dissolved in an organic solvent and it’s retained by the membrane 
(Patrizia Marchetti, 2014). 
Organic solvent nanofiltration is mainly applied in the following processes: 
 Concentration for solute enrichment and solute recovery 
 Solvent Exchange 
 Purification for impurities removal 
 Catalytic processes, crystallization and chemical synthesis assisted 
process 
All of the above applications are widely used in pharmaceuticals. For the special 
chemicals industry, the biggest usage of OSN is in catalytic processes, while with base 
and consumer chemicals the applications focused on concentration by solvent 
enrichment, recovery and impurity removal. The OSN solute enrichment technique 
applied to the pharmaceutical industry is mostly used for the isolation and concentration 
of antibiotics, pharmaceutical intermediates and peptide from organic solvents with 
examples such as the active pharmaceutical ingredient (API) recovery being applied in 
industrial processes. Another rise of solute enrichment via OSN but in the chemical 
consumers’ industry was the increasing demand for natural and biological health 
products such as extractions of vitamins and antioxidants from herbs and plants. (Patrizia 
Marchetti, 2014) Another usage of OSN solvent recovery is in two-stage membrane 
cascade configurations, replacing liquid−liquid, liquid−solid and liquid−gas purification 
techniques that require large quantities of organic solvents and are prejudice for the 
environment (Patrizia Marchetti, 2014). 
When it comes to API purification, the process accounts for around half of the 
costs in the pharmaceutical industry. A lot of studies show that OSN may be a solution 
for this purification phase, still, it has the problem of most of the impurities that should be 
removed tend to attack the polymeric membrane due to their reactivity. Adding to that, 
another limitation that comes with API purification using OSN is its low rejection and low 
yield of the product. (Patrizia Marchetti, 2014) Due to that fact the majority of the 
purification studies were reported in a laboratory scale but not in industrial scale, another 
problem of scale/up is the fact that when the MW of the compounds to separate is similar, 
it is necessary to use more than one stage filtration. Usually, two-stage counter-current 
NF cascade is preferred. (Silva, 2012) The membrane cascade mode has been applied 
in the purification of saccharides instead of using the usual simulated moving bed 
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chromatography, and even though it was necessary to have more than two-stage 
configuration, an economic evaluation showed that the more stages the more 
competitive it was compared with the chromatography (Patrizia Marchetti, 2014).  
 
2.1.2. Transport Phenomena in Nanofiltration Membranes 
The performance of a nanofiltration membrane is described by the solution-
diffusion model, which assumes that the solvent and the solute don’t interact with each 
other. It also assumes that the solute permeation is driven by the gradient in chemical 
potential of the solute i, Eq Equation 1. (Mulder, ChII Materials and materials properties, 
1996)  
𝐽𝑖 = − 𝐿𝑖
𝑑µ𝑖
𝑑𝑥
 = − 𝐿𝑖
𝑅 𝑇 𝑑 ln(𝛾𝑖 𝐶𝑖) +  𝜗𝑖 𝑑𝑝 
𝑑𝑥
 
Equation 1. Solute flux of the membrane  
Where the chemical potential 𝑑µ𝑖 is dependent on solute concentration Ci 
(mol/m3) and on the pressure difference across the membrane 𝑑𝑝. R is the gas constant 
(8.31 m3⋅Pa⋅K−1⋅mol−1), T is the absolute temperature (K), 𝛾𝑖  is the activity coefficient 
and 𝜗𝑖 is the molar volume (m3/mol). Considering that the solution is diluted and applying 
Fick’s law, Equation 2, becomes simplified 
𝐽𝑖 = 𝑃𝑖  Δ𝐶𝑖    Equation 2. Solute flux of the membrane  
Where 𝑃𝑖 and Δ𝐶𝑖 are the permeability and the concentration difference across 
the membrane of the solute respectively. Applying the same considerations for the 
solvent, the solvent flux is described as  
𝐽𝑣 =
(Driving Force) 
(𝑇𝑜𝑡𝑎𝑙 𝑅𝑒𝑠𝑖𝑠𝑡𝑎𝑛𝑐𝑒)
=
ΔPeff 
𝜂𝑊 ∗ 𝑅𝑡𝑜𝑡
 
 
Equation 3. Solvent flux of the 
membrane  
Which in this case depends on the effective pressure difference across the 
membrane, Δpeff, Equation 4 . 
Δpeff = Δp+ ΔΠ Equation 4. Effective Pressure of a membrane 
This membrane difference is related to the osmotic pressure difference ΔΠ of the solutes 
at the two sides of the membrane. The selective transport through the membrane causes 
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a concentration increase of the less permeable solute near the boundary layer, this 
phenomenon known as concentration polarization is illustrated in Figure 2.  
 
Figure 2. Concentration polarization phenomenon in nanofiltration. (Nanofiltration Separations 
Part 2 (Nanotechnology), 2019) 
The increase in osmotic pressure leads to a decrease in the pressure, effective 
driving force. Nevertheless, the decrease in flux can also be caused by increasing of total 
resistance, Equation 5, which usually it’s due to the concentration polarization or fouling. 
(Patrizia Marchetti, 2014) 
 
Where Rf is the resistance caused by foulants and Rm is the resistance due to the 
membrane alone. The foulants resistance, Rf, is the resistance caused when a 
particle is entrapped in a pore, when the solubility limits of inorganic material are 
exceeded and they tend to deposit in the membrane causing the formation of a cake, 
or even when the solutes have chemical affinity and tend to interact with the 
membrane material causing adsorption of solutes to the pores walls. The foulants 
resistance can be reduced by chemical cleaning of the membrane. The resistance of 
the membrane, Rm, also known as the hydraulic resistance, is an intrinsic property of 
the membrane that reflects the pore structure and the interaction of the membrane 
and passage of the solvent in the same. This resistance has almost no impact in the 
total resistance. (A.Piry, 2012) 
 In order to select the best membrane to perform the fragment condensation 
synthesis, it’s necessary to compare the different membranes at different conditions.  
The conventional procedure to compare membranes it’s by analysing the filtration 
performance and to calculate the membrane effective rejection, Reff. Solute rejection 
is an intrinsic property of the membrane related to the permeate concentration 
defined by Equation 6. 
 
Rtot =  Rf  +Rm   Equation 5. Total Resistance 
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 𝑅𝑒𝑓𝑓 (%) = (1 − 
𝐶𝑝,𝑖
𝐶𝑚,𝑖
) ∗ 100 Equation 6. Effective rejection of a membrane 
Where Cp,i is the concentration permeate side and C,mi is the concentration in the 
retentate side near the membrane. There is no accurate method to measure the 
concentration of the retentate Cm,i, therefore it is necessary to introduce the concept of 
observed rejection, Robs, which is inversely proportional to the measurable bulk 
concentration Cb,I, Equation 7. 
𝑅𝑜𝑏𝑠 (%) = (1 −  
𝐶𝑝, 𝑖
𝐶𝑏, 𝑖
) ∗ 100  Equation 7. Observed rejection of a membrane 
Where Cp,i is the concentration at permeate side and Cb,i is the concentration in 
the feed bulk. This bulk concentration, Cb,i, is smaller than the concentration near the 
membrane, C,mi, due to the concentration polarization.  
As can be seen from the above reducing the concentration polarization resistance 
is of major importance to the membrane process. This could be achieved via intensifying 
the mass transfer within the membrane devise. Typically, at a large scale applications 
this is achieved via high recirculation rate provided by a pump. At a laboratory scale 
membrane devises sometimes mixing is provided via agitators. In order to understand 
the effects of mass transfer it is necessary to calculate some dimensionless number for 
agitation that determine the mass transfer performance. The data used are presented in 
Table 1. 
 
 
Table 1. Dimensionless Numbers in agitation 
Number Symbol Definition 
Pumping NQ Related to impeller capacities 
Reynolds NRe Laminar flow if Re<2000; turbulent flow if Re>4000 
Power Np Correlates Reynolds number with power requirements 
  
Reynolds number for fluids in pipes is given by Equation 8, while in the case of 
the shaft power required to drive an agitator the Reynolds number is given by Equation 
9, which can also be referred as impeller number due to the fact that is based on the 
impeller agitation. Depending on the agitation there can be three different types of flow 
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regions, laminar (Reynolds< 2000), transactional and turbulent (Reynolds> 4000). In an 
agitated tank, once a vortex starts to form near the impeller or stirrer it is a sign of a 
transitional regime. When this vortex begins to be at the surface the Reynolds number 
is usually above 4000 and the power is only dependent on the geometry of impeller 
hence the region is turbulent (Sinnott, R. K., 2005). 
𝑅𝑒 =
𝐷 𝑢 𝜌 
𝜇
 Equation 8. Reynolds Number for fluids in pipes 
𝑅𝑒 =
 𝐷2 𝑁 𝜌 
𝜇
 
 Equation 9. Reynolds Number for agitation speed 
𝑁𝑝 =  
𝑃
 𝜌 𝑁3 𝐷5
 
Equation 10. Power Number for impeller 
 
Where  
D: Diameter (m); 
u: Superficial axial velocity (m/s); 
ρ: Density (kg/m3); 
µ: Viscosity (kg/ m s);  
N: agitator speed (s-1); 
P: Power (W); 
 
The power a stirrer/ impeller needs to mix a solution is given by the power 
number. This number is related to Reynolds by Figure 3.  
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Figure 3. Power Number vs Reynolds Number (Sinnott, R. K., 2005). 
This dependency is only effective for Reynolds below 103, above this value the 
power number is constant. As seen by Equation 10 the power number relates resistance 
with inertia forces. The efficiency of a stirrer/ impeller is given by the ration of power 
number and the pumping number, in which the smaller the ration the more efficient the 
impeller. (Chudacek, 1985) 
 
2.1.3. Cascade and diafiltration modes 
A cascade, is an array of separation units, also called modules, organized in 
stages, hence each cascade is composed of at least two separation units. There are 
ideal and non-ideal cascades. An ideal cascade design is obtained when the 
concentration of the recycled stream is equal to the retentate streams they are mixing. 
Even though ideal cascade designs are hard to achieve, usually the experimental 
procedures are approximated to an ideal cascade. (Ali K. Alshehri, 2015)  
Regarding the modes, there are two main configurations of operating a cascade, 
the open-loop in which the permeate from the second stage goes to drain, and the 
closed-loop, in which the permeate of the second stage passes to the first stage, 
gradually diluting the content of the first stage.  Considering that in most cases the 
rejection is not 100 %, the closed-loop cascade configuration modes require recycling of 
the solvent containing impurities, which means to recirculate this solvent back to the 
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separation stages. In this study the configuration is a countercurrent recycle closed-loop 
based on three basic sections: 
 the feed stage; 
 the stripping section, in which there is an increase in recovery of product, this 
section is below the feed; 
 the enrichment section, in which there is an increase in product concentration, 
this section is above the feed. 
The countercurrent two-cascade system has two major configurations, the 
stripping configuration and enriching configuration. The stripping configuration, is 
characterized by recycling of the permeate of the second stage to the first stage with the 
retentate of the first stage feeding the second stage. The enriching configuration is 
characterized by the opposite, with the permeate feeding the second stage and the 
retentate recycles to the first stage, Figure 4. One of the advantages of membrane 
cascade is that in this configuration the purification process is faster than with a single 
membrane without compromising of the yield or purity. (Ali K. Alshehri, 2015)   
Considering the enriching configuration with more than two stages, the concentration of 
the final product decreases from one stage to the other as the number of membranes 
increases, hence the number of stages in a cascade should be as small as possible. 
Increasing the number of stages also has the disadvantage of more complex process 
control.  (Villani, 1979)  (Benedict, 1981) In order to increase the recovery of the product, 
the configuration used in this work is a version of a countercurrent enriching cascade, 
Figure 4.  
 
 
Figure 4. Countercurrent recycle cascade (Silva, 2012). 
Regarding the diafiltration, it is a technique for the removal of permeable solutes 
from a solution in order to obtain high purity products. Diafiltration is a tangential flow 
filtration method in which there is addition of solvent to the pressurized side of the 
membrane and it consists of the following three basic phases: 
 Concentration by passing the feed solution through membranes to obtain similar 
concentrations of low MW components in the retentate and the permeate; 
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 Addition of a diafiltration fresh solvent to purify the retentate bringing the volume 
to its initial value; 
 Concentration of high MW solutes in retentate in the enriching stage. 
(ScienceDirect, 2019) 
There are different modes of operation and configuration for the diafiltration to 
enhance mass transfer and to maximize energy efficiency. These modes are continuous 
also referred as constant volume diafiltration, Figure 5 A), and batch, Figure 5 B), which 
can be performed by sequential dilution or by volume reduction. The main difference 
between batch and continuous is on the solvent addition mode. 
A B 
 
 
Figure 5. Flow diagram of Diafiltration configurations, (A) Continuous mode and (B) Batch mode 
(Kovács). 
The continuous diafiltration the mode used in the present study, is based on the 
wash out of the lower MW solutes in the retentate by solvent addition at the same rate 
that the permeate leaves the system hence the volume of the system and the product 
concentration are constant. The continuous diafiltration process is more complex due to 
the fact that it requires a pump in order to add the solvent at a constant rate. This pump 
may also lead to a contamination of the product. Still one of its advantages is the fact 
that the concentration of the retentate is kept constant throughout the process (Fane, 
2005) (Livingston, 2009) (Silva, 2012). 
The batch diafiltration by sequential dilution is performed in cycles and the usage 
of solvent is smaller compared to the prior mode. In this case before the solvent addition, 
smaller solutes are removed while the concentration of retentate increases. Afterwards 
there is addition of fresh solvent and after this addition again the retentate is 
concentrated. In the case of batch diafiltration by volume reduction there is initially a 
concentration of the sample followed by a dilution to the original sample volume. For both 
batch modes, once the separation process is completed, the final product is obtained in 
the feed reservoir, and the final product has the same volume and concentration as the 
initial starting solution (Science Direct, 2019). In Table 2 is a summary for comparison of 
batch and continuous diafiltration modes in industrial-scale usage.  
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Table 2. Comparison of batch and continuous diafiltration (Kovács) 
Characteristics/ Modes Continuous Batch 
Control investment High Low 
Feed volume flexibility Low High 
Residence time Low High 
Module efficiency High Low 
Energy consumption Low High 
  
2.1.4. Membrane cells 
In membrane filtration, after the feed material is in contact with the membranes, 
the results are two streams, the permeate and the retentate. The permeate is the material 
that passes through the membrane’s pore due to its smaller size. The retentate is the 
larger material that has a larger size than the pores and therefore is retained by the 
membrane. The separation unit of a membrane is called module and it can be flat or 
tubular. In this work the modules used are flat, Figure 6, with the pressure being applied 
in a parallel way to the membrane surface (Silva, 2012) (Vandezande, 2008). 
 
 
Figure 6. Schematics of the top view of the custom-made membrane cells used for the 
experimental set-ups of this work (Lin, 2007). 
13 
 
Comparing this mode to the dead-end flow mode, in which the feed and the 
permeate are flowing perpendicular to the sheet, the cross-flow is more efficient and 
used in industry, due to the fact that the parallel feed flow creates a gradient 
concentration on the membrane surface that consequently decreases the fouling 
tendency, polarization problems as well as cake formation (Silva, 2012) (Vandezande, 
2008).  
The first type of flat membranes cells to be used have the permeate coming from 
the top of the cover, Figure 7. These type of cells were also used in the second 
configuration for the diafiltration (Figure 22, Chapter 3.4.3). 
 
 
 
Figure 7. Schematics of the front view of the custom-made membrane cells used for the 
experimental set-ups used in single screening and diafiltration. Adapted from (Lin, 2007) 
In the cascade (Figure 20, Chapter 3.4.2) and first configuration of diafiltration 
(Figure 21 Chapter 3.4.3) cells have a magnetic stirrer, Figure 8.  
 
 
 
Figure 8.  Schematics of the front of the custom-made membrane cells used for the experimental 
set-ups of this work. Adapted from (Lin, 2007) 
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 2.2. Peptide Synthesis 
Proteins are polypeptides, which are the assembling of up to 50 amino acids, 
linked to each other by peptide bonds. According to the IUPAC, when the ensemble of 
amino acids results in intermediate relative molecular weight peptide, it is denominated 
an oligomer.  
Due to the importance of proteins and peptides in medicine, healthcare and 
biochemistry, one of the focuses of peptide research has to do with their synthetic 
production at a less costly price for the consumer. This works focuses on the study of 
the glucagon synthesis, which is a hormone that increases the blood sugar concentration 
preventing the body to achieve hypoglycaemia and it is used to treat diabetes type 2 (UK 
Gov, 2019). 
There are currently twenty known natural amino acids for proteins building blocks, 
all of them with the same basic structure. Amino acids are chiral molecules and therefore 
have four groups attached to the central asymmetric α-carbon. The amino group (NH2), 
called N-Terminus, and the carboxyl group (COOH) also called C-Terminus, represented 
on the right side, the hydrogen and the side chain group that confers different properties 
to the amino acids. Only L- enantiomers are used in cells and are incorporated in 
proteins, and therefore by convention, the amino group is always represented in the left 
side of the molecule while the carboxyl group is on the right (Termofischer Scientific, 
2019). 
The first peptide to be synthetized and also the simplest one was glycyl-glycine, 
by Fischer and Fourneau in 1901. Their technique is still in usage nowadays to produce 
semisynthetic peptides. It consisted of removal of the H2O of the carboxyl group of one 
amino acid and afterwards joining this amino acid with the amino group of another amino 
acid. Initially, in order to avoid side reactions, all the groups were protected, prior to 
coupling, it was necessary to deprotect the amino group of the first amino acid and the 
carboxyl of the added amino acid, Figure 9. The stepwise principle (sequential addition 
of amino acids) with protection of all groups in both amino acids followed by deprotection 
of the amino-terminal group of the first amino acid and the carboxyl group of the second 
amino acid in order for these two sites to react, as well as, the removal of all protecting 
groups once the peptide sequence is complete, also called cleavage, are necessary 
steps in the current synthesis protocols. 
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Figure 9. Schematic representation of the synthesis of a peptide. N, C and R represent the amino, 
carboxyl and side chain functional groups respectively (Termofischer Scientific, 2019). 
Regarding the protection and deprotection of the different groups of amino acid, 
there are two main sets of conditions summarized in Table 3. Since the hydroxyl 
functional groups have similar reactivities, it is advantageous to use the orthogonal 
strategy allowing the efficient protection of several temporary protecting groups during 
the peptide synthesis. 
 
Table 3. Protection and deprotection conditions (Termofischer Scientific, 2019). 
Protection Deprotection Coupling Cleavage Wash 
Boc/ Blz TFA  
Coupling agent 
in DMF 
HF, HBr, 
TFMSA 
 
DMF 
Fmoc/  tBut Piridine TFA 
 
 
In case the amino acid N-terminal is temporary protected with tert-butoxycarbonyl 
(Boc), then the side chain needs to be permanently protected with benzyl (Bzl) (side 
chain functional groups are permanently protected throughout the reaction and are only 
removed once the reaction is completed), while the cleavage requires strong acids such 
as anhydrous hydrogen fluoride (HF) or trifluoromethanesulfonic acid (TFMSA). In the 
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case of HF, before its cleavage the Boc group must be removed with TFA/DCM to 
prevent t-butylation. Meanwhile, in order to reduce the risk of unwanted side reactions in 
the cleavage step, scavengers such as anisole, which are molecules that react with the 
cationic species released while removing the protecting groups, need to be added. After 
the scavengers’ addition and the HF cleavage reagent has been evaporated, the 
synthetized peptide is obtained from the solution by washing with DMF. In the case of 
the cleavage with TFMSA, one of its advantages is that it does not require the removal 
of Boc group, but unlike HF, TFMSA is not volatile and therefore cannot be removed by 
evaporation. In this case the peptide must be precipitated from the solution using dry 
solvent ethyl ether. Due to the fact that peptide linkages can be affected by the acidic 
conditions the Boc strategy is usually not applied industrially unless basic medium 
conditions cannot be applied to the peptide (Bachem AG, 2016) (Termofischer Scientific, 
2019) (Tarfah I.Al-Warhi, 2012). 
In case the peptide can be synthesised in basic conditions, then the Fmoc 
strategy is preferred for the protection of the N-terminal. The base-labile protecting group 
9-fluorenylmethoxycarbonyl (Fmoc) requires tert-butyl (tBu) for the side chain protecting 
groups and a base deprotection group such as piperidine in DMF. One of the problems 
occurring in Fmoc strategy is the Diketopiperadine (DKP) formation in side reactions, 
which is frequent when proline is one of the first two residues, which is not verified in 
glucagon sequence, Figure 10. The formation of aspartimide has also been reported in 
both acidic and basic medium synthesis with aminoacids’ sequences such as Asp-Gly, 
Asp-Ala or Asp-Ser, which is also not verified for the glucagon, Figure 10 (Novabiochem, 
2014) (Thermofisher Scientific, 1998). 
 
His -Ser - Gln- Gly -Thr -Phe –Thr- Ser -Asp- Tyr- Ser- Lys - Tyr.- Leu- Asp -Ser –Arg- Arg- Ala- Gln- 
-Asp -Phe -Val - Trp -Leu -Met –Asn- Thr  
Figure 10. Glucagon Peptide sequence 
Regarding the protection of the carboxyl group of the first aminoacid, this is only 
required for the liquid-phase peptide synthesis due to the fact that with solid phase the 
resin/ solid support will serve as protecting group. Still, it is necessary to activate the C-
terminal carboxylic acid of the remaining added aminoacids with 
dicyclohexylcarbodiimide (DCC) or diisopropylcarbodiimide (DIC) in order to react this 
site with the amine group of the forming peptide. DCC strategy is the most widely 
applicable due to the fact that can be used with the most common solvents know in 
peptide synthesis. Still one of the problems of both DCC and DIC it is the racemization. 
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To avoid this phenomenon it is necessary to add 1-hydroxybenzotriazole (HOBt) when 
synthesising in acidic medium (Boc strategy) and benzotriazol-1-yl-oxy-
tris(dimethylamino)phosphonium hexafluorophosphate (BOP) or 2-(1H-benzotriazol-1-
yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU) for Fmoc strategy due to 
the fact that they require activating bases to mediate aminoacid coupling (Tarfah I.Al-
Warhi, 2012). 
Nowadays peptide synthesis can be performed either in solution/ liquid phase 
(LPPS) or in solid phase (SPPS). The first know approach, the solution phase, gave du 
Vigneaud, the Nobel Prize of Chemistry in 1955 for the synthesis of the first oligopeptide 
in solution phase (the hormone oxytocin). The solid-phase approach was only 
successfully applied years later by its pioneer Bruce Merrifield, who was laureate in 1984 
with the Nobel Prize of Chemistry for his work in the SPPS approach. (Byrnes, 1994) 
These two approaches are described below. 
In the solution-phase synthesis, the aggregation occurs in a solution phase and 
therefore, a C-terminal protecting group is needed on the first amino acid. In this 
synthesis, the Fmoc strategy is widely used due to the fact that Fmoc removing agent 
tris(2-aminoethyl)amine (TAEA) will form the dibenzofulvene, an adduct that can be 
extracted in phosphate buffer (pH 5.5). The Fmoc removing agent can also be 4-
(aminomethyl) piperidine, with the disadvantage that may form precipitates or emulsions. 
The solubility of a protected fragment is not accurate, and therefore the coupling in a 
liquid-phase solution is difficult and it can take long periods of time, which makes this 
approach more appropriate for low molecular weight peptides.  
The SPPS approach, schematized in Figure 11, is an approach for peptide 
synthesis based on assembly of amino acids on an insoluble polymeric resin bead 
functionalized with reactive groups that will link to the peptide chain. (Daniel Carbajo, 
2019) The first step of the synthesis is assembling the carboxyl group of an amino acid 
to the resin, with this first amino acid being dependent on the resin used. Resins such 
as Rink amide resin, Pal resin, and Sieber resin are used in the Fmoc amides method. 
Whereas Wang resin, Sasrin resin, HMPB resin, trityl chloride resin, and 2-chlorotrityl 
chloride resin are used in the Boc acids method. (Wen Hou, 2017) Then, the N-terminal 
formed will attach to a new amino acid carboxyl group while the reactive groups are 
protected by a protecting group as explained previously. After each amino acid is added 
and the reaction is completed, the resin has to be washed with DCM or DCC. The 
synthesis in a polymeric support allows fast preparation of long peptides, still a restriction 
of the solid phase synthesis is the interaction of the amino acids with the resin and how 
it affects the coupling kinetics. To avoid these mass transference problems, it is required 
the use of excess reagents, that are removed by washing the resin in each coupling. 
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(U.S.A Patent No. US 9 260 474 B2, Method for solid phase synthesis of liraglutide, 
2016)  
 
 
Figure 11. Representation of the stepwise solid phase synthesis, in which the peptide chain is 
built up from the C-terminal residue while bound to a polymeric resin support (Wen Hou, 2017) 
During recent years, variations of these two approaches have been studied, 
including the usage of a PEG-linker, or also a Hub backbone, Figure 12, instead of a 
resin. The PEG linker is a molecule with the capacity of loading one peptide, while the 
Hub-1 is a soluble polyfunctional organic backbone molecule with higher peptide loading, 
three reactive alcohol groups. The Hub-backbone has the ability to covalently bind to a 
terminal of an initial monomeric unit. (Patent No. WO 2017/042583 Al, Defined monomer 
sequence polymers, 2017)   
 
 
Figure 12. Hub-1 chemical molecular structure with fragments n1 and n2 
After each coupling the excess unreacted reagents and by-products are 
separated from the growing polymer by diafiltration membrane processes. According to 
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the literature and using MATLAB simulations, when comparing single membrane and 
diafiltration processes in membrane cascade, diafiltration is more efficient due to the fact 
that the yield and purification of the product increase. (Patrizia Marchetti, 2014) Figure 
13 is a schematic representation of peptide synthesis process with the PEG-linker as a 
support for the iterative coupling of aminoacids using the Fmoc strategy as the protection 
scheme. (Patent No. WO 2017/042583 Al, Defined monomer sequence polymers, 2017) 
 
 
 
Figure 13. Schematic representation of a peptide synthesis via step-wise process with a PEG-
linker (Patent No. WO 2017/042583 Al, Defined monomer sequence polymers, 2017) 
Another approach, which is a variant of the sequential linkage of amino acids, is 
the fragment condensation approach. The fragment condensation can be both in solution 
or in solid phase using a support, Figure 14, and instead of iterative coupling of amino 
acids, the goal is to couple fragments (known sequence of amino acids that linked 
together form a peptide). The protecting schemes presented in Table 3 are also applied 
in the fragment condensation approach for the fragments protection. 
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A B 
  
Figure 14. Strategies for the assembly of peptide Fragments. (A) Fragment condensation, carried 
out in solution phase; (B) Fragment condensation carried out in solid phase. The three different 
protected fragments are generated by stepwise solid phase synthesis, followed by released of 
two fragments from their original support and condensation on the new resin support that contains 
the first fragment. (Kent, 1988) 
Taking in consideration the glucagon case study of this thesis, the fragment 
condensation is realized in liquid phase using the soluble Hub-backbone technology as 
the support for the fragments coupling and the Fmoc strategy as the protection scheme. 
The excess unreacted fragments are separated from the growing polymer by membrane 
processes, more precisely diafiltration cascade.  
Table 4. Characteristics of the fragments 
Fragment MW (g/mol) Fmoc off, Aniline on Hub+ Fragments 
1 1495 1347 5394 
2 1635 1487 5769 
3 2160 2012 7389 
4 1597 1448 5700 
 
The proposed 4 fragments have molecular weight between 1495 and 2160, Table 
4 and after the Fmoc deprotection and C-terminal capping the MW of fragments will 
range from 1347 to 2012, Figure 15 and Figure 16.  
 
 
Figure 15. Example of fragments from DG peptide 
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Figure 16. Example of fragments with Fmoc off, and aniline capping 
Once the first coupling of a fragment to each alcohol occurs, the total MW of the 
molecule is about 8000Da, while the impurities and the by-products have around 
2000Da. After the coupling of the second fragment, the total MW of the molecule is about 
20000Da. (China Patent No. EP 3 196 206 A1, Method for preparation of liraglutide, 
2017) (China Patent No. CN 104045705 A, Synthetic method of liraglutide, 2014) Taking 
in consideration the MW of the fragments, desired peptide, reagents and by-products, 
the solution tested was composed of poly(ethylene glycol) (PEG) oligomers with MW of 
400, 1000, 2000, 8000 and 20000 Da in tetrahydrofuran (THF), which is an appropriate 
solvent for the diafiltration due to the fact that it maintains the functionalised polymer in 
solution. 
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3 . Materials and Methods 
This chapter explores the materials and methods used in each experiment. 
Different types of membranes were used in this work, some of them were prepared 
previously by colleagues, Chapter 3.1, while other were prepared, Chapter 3.2. 
3.1. Membranes studied but not prepared 
The membranes not prepared but studied in this work, PEEK and PBI are 
categorized as Integrally Skinned Asymmetric (ISA) membranes. These membranes 
have ticker particles in the bottom than in the surface, hence the porosity, composition 
and structure vary across the membrane, Figure 17.  
 
 
Figure 17. Schematic representation of ISA membranes. Adapted from (R.W., 2004) (Mulder, 
Ch I Introduction, 1996) 
In these membranes the fluxes are higher than the usual due to the fact that the 
membrane is thinner and the microporous of the top has higher strength. (Baker, 2004) 
Both membranes were made by wet phase inversion technique, in which there is a phase 
inversion in the polymer from liquid to solid. Phase solidification is achieved with the 
following steps: 
 Separation of the polymeric phase from the phase poor in polymer; 
 Solidification of the polymeric liquid phase.  
Even though the PBI and PEEK membranes were not prepared by me in the 
laboratory, the preparation process for these ISA membranes is described below and 
their structure is presented in Table 5.  
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Table 5. Chemical structure of of typical polymers used to prepare PEEK and PBI OSN 
membranes (Irina Boyanova Valtcheva, 2015) 
Polymer Chemical structure 
Poly(ether-ether-ketone) 
(PEEK) 
 
Polybenzimidazole (PBI) 
 
 
 
The PEEK membranes  were prepared as follows: PEEK powder VESTAKEEP® 
4000P was dissolved at a concentration of 12 wt. % in a mixture of 3:1 wt. % 
methanesulfonic acid (MSA) and sulphuric acid (SA) at room temperature until the 
polymer solution was homogeneous.  Prior to casting the polymer solution was left to dry 
for 72-96 hours at 50 °C for PEEK_50ºC, and at 80 °C for PEEK_80ºC. (João da Silva 
Burgal L. P., 2016) 
The PBI18m5j2005 membrane was prepared has follows: Celazole® S26 was 
diluted in N,N-Dimethylacetamide (DMAc) to 18 wt% polymer concentration until the 
solution was homogeneous. Prior to casting on non-woven polypropylene, the 
membranes were left to dry. Afterwards, the membranes were immersed in water at room 
temperature for 24h. Once the 24h were completed, the membranes were washed with 
IPA in order to perform crosslinking by immersion in a solution containing 3 wt% DBX in 
acetonitrile. After crosslinking, the membranes were immersed for 4 h in a solution of 
PEG400/IPA (1:1) solution. The IPA will remove residual reagents and the PEG400 will 
preserve the pore structure and allow dry storage. This membrane was also modified 
with j2005 polymer brush. The PBI18j1000 was prepared the same way PBI18m5j2005 
with the difference that this time it was modified with a J1000 polymer brush (Irina 
Boyanova Valtcheva, 2015). 
The summary of the membranes prepared by colleagues is presented in Table 6, 
as well as the filtration effective area of the discs for the single screening.  
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Table 6. Characteristics of the membranes used previously prepared by colleagues 
Membrane code Description Membrane disc 
Area (cm2) 
PBI18m5j2005 PBI 18 wt%, Cross-linked with DBX, modified with J2005 polymer 
brush 
52 
PBI18j1000 PBI 18 wt%, Cross-linked with DBX, modified with J1000 polymer 
brush 
52 
PEEK 50ºC PEEK support powder VESTAKEEP® 4000P 12 wt% in a mixture of 
3 : 1 wt% MSA: SA, dried at 50ºC 
14 
PEEK 80ºC PEEK support powder VESTAKEEP® 4000P 12 wt% in a mixture of 
3 : 1 wt% MSA: SA, dried at 80ºC 
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3.2. Membranes prepared 
The membrane prepared in the lab is a UF membrane with polydopamine coating, 
Figure 18. This coating is based on the same coating used by Jiang et al. with dopamine 
hydrochloride. (J.H. Jiang, 2011) 
 
 
Figure 18. Self- Polymerization process of the dopamine monomer on the UF membrane 
(Kyoung-Yeol Kim, 2014) 
The two catechol groups allow reactions with amine and thiol groups creating a 
quinone molecule with strong adhesion to solid surfaces. (Tomé, 2016) In order for the 
oxidation (oxygen present in the air) of dopamine to take place, it is necessary an alkaline 
solution. In case the PEG was in aqueous solution, if we tested the PE membrane and 
compared it when it has the polydopamine coating, it would be perceptible that because 
polydopamine coatings are characterized for enhancement of hydrophilicity, the flux of 
the PE membrane coated would be smaller than the PE membrane without coating. 
(McCloskey, 2010) (Tomé, 2016) In this polymerization process a mixing plate improves 
the oxidation strongly pH-dependent (Kyoung-Yeol Kim, 2014) (V. Ball, 2012). 
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3.2.1. Chemicals 
PE sheets (SKL; BS) were purchased from SK Energy Co. Ltd. (Soul Republic of 
Korea). TRIZMA Hydrochloride (1M) and dopamine hydrochloride were purchased from 
Sigma-Aldrich (Germany) both used as additive. The NaOH (0.5 M) was used as a 
neutralizer. 
3.2.2. Membrane Preparation 
These membranes were prepared by dip-coating in alkaline conditions. Place 
space separators between 3 sets of PE sheets (SKL: BS) sheets. This set was placed in 
a 2L beaker filled with water and with a magnetic stirrer. For PDA 2gL, dissolve 10mM/L 
(3.15g/2L) TRIZMA hydrochloride in a beaker solution and afterwards dissolve 2g/L of 
dopamine hydrochloride. The formation of polydopamine particles is accompanied by a 
colorimetric solution change to dark brown. Once the solution presents a homogeneous 
brown colour, NaOH (0.5 M) was added until the pH reaches 8.5. (V. Ball, 2012) Each 
set of membranes was kept in solution for 18h, 30h and 40h. After the respective time, 
the PE sheets were taken from the beaker and washed with acetone at room 
temperature. Finally, the membrane was air dried for 1h at room temperature to remove 
the excess solvent. The PE membranes prepared for this work are listed in Table 7. For 
the PDA 4g/L the only difference from the previous preparation is that the concentration 
of TRIZMA hydrochloride and dopamine hydrochloride doubled to 20mM/L and 4g/L 
respectively. There is no specific rule regarding the order of applying the TRIZMA 
hydrochloride and the dopamine hydrochloride, because the reaction of polydopamine 
adhering to solid surfaces only starts once both reagents are in the solution. 
Table 7. Summary of the PE membranes prepared 
Membrane Code Description MWCO 
PDA2gL_18h PE coated with 2g/L of PDA for 18 h N/A 
PDA2gL_30h PE coated with 2g/L of PDA for 30 h N/A 
PDA2gL_48h PE coated with 2g/L of PDA for 48 h N/A 
PDA4gL_30h PE coated with 4g/L of PDA for 30 h N/A 
PDA4gL_48h PE coated with 4g/L of PDA for 48 h N/A 
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3.3. Solvents and Solutions  
The PEG is a polymer of monomers of ethylene oxide which could be used for 
different applications. Its length defines its applications. By definition PEGs have MW 
minor than 20000 g/mol and usually the MW proceeds the PEG classification. Above 
20000 g/mol the classification is polyethylene oxide (PEO) and the classification 
polyoxyethylene (POE) applies to any molecular weight. Below 200 g/mol the polymer is 
a viscous liquid, between 200-2000 g/mol it’s a wax, and above 2000 g/mol it’s an opaque 
white crystal. PEGs are produced by an exothermic polymerization of water and ethylene 
oxide. Due to the fact that PEG has low toxicity levels, it’s biocompatible and 
biodegradable and is also metabolized by the liver and the kidneys, PEG is widely used 
in the pharmaceutical industry. PEG is inert and it’s biologically safe and therefore its 
usage via oral, dermal and intravenous administration is approved by the FDA. In the 
present study the solution with PEG was used due to its similar MW and the MW of the 
fragments. The solution (1g/L) used in the single screening was composed of PEG400, 
PEG1000, PEG2000, PEG8000, PEG2000 in the ratio 1:1:1:1:1. The solution used in 
the cascade and diafiltration configurations was composed of PEG2000, PEG8000, 
PEG20000 in the ration 1.5:1:1. The Polyethyleneglycol ether (PEG, MW≈ 400 gmol-1) 
and Polyethyleneglycol ether (PEG, MW≈ 20000 gmol-1) were purchased from Merck. 
Polyethyleneglycol ether (PEG, MW≈ 2000 gmol-1), Polyethylene glycol ether (PEG, 
MW≈ 8000 gmol-1) were supplied by Sigma-Aldrich (Germany). Polyethyleneglycol ether 
(PEG, MW≈ 1000 gmol-1) was supplied by Fluka Research Chemicals (Germany). 
Tetrahydrofuran (THF) is a colourless low-viscosity liquid ether and the ability of 
oxygen atom to coordinate with a magnesium ion, makes THF a widely used solvent for 
Grignard reagents. Due to that fact, THF is also widely used in chemical synthesis hence 
it was used as a solvent for the PEG solution. THF was purchased from VWR Prolabo 
Chemicals.  
 
 
 
 
 
 
 
 
28 
 
3.4. Filtration Configurations 
3.4.1. Single Membrane Filtration 
 
This work starts with the study of different membranes in a single- module 
filtration process due to the fact that the simplest membrane process design is with a 
single membrane filtration. The cross-flow rig system used for single membrane 
screening is schematized in Figure 19. It is constituted by feed tank with the PEG solution 
and two single membrane cells that have permeate and retentate outputs. The 
membrane cells discs tested had a membrane sheet diameter of 52 cm2 for the PBI 
membranes in the single screening and for the rest of the screening their diameter was 
14 cm2. The samples, named P1, P2 and R and analysed in the HPLC. The pressure on 
the system is provided by the Amersham Pharmacia Biotech P-900 HPLC pump that 
provides a feed flow rate of 50 mL/min. In every experiment, before each filtration the 
system was washed with pure THF in the set-up conditions to wash impurities and 
prevent contaminations. Samples of permeate and retentate were collected 2 in 2 h 
during the day. The system was left to run at night.  
 
 
 
Figure 19. Schematic representation of the single stage organic nanofiltration membrane process 
integrating a cascade of 2 membrane units for purification. 
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The membranes tested and the pressures applied to the single system are 
presented in Table 8. 
Table 8. Membrane code and pressure applied to the system 
Membrane code Pressure applied (bar) 
PBIm5j2005 20 
PBIj1000 20 
PEEK50 5 
PEEK50 10 
PEEK50 20 
PEEK80 5 
PEEK80 10 
PEEK80 20 
PDA2gL_18h 5 
PDA2gL_18h 10 
PDA2gL_18h 15 
PDA2gL_18h 5 
PDA2gL_30h 5 
PDA2gL_48h 5 
PDA4gL_30h 5 
PDA4gL_48h 5 
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3.4.2. Cascade configuration 
In order to improve the performance of the membrane one can place several 
single modules in series. This configuration, Figure 20, is called recycling cascade and 
its phenome is based on the passage of permeate of the first membrane to the second 
membrane to be again separated in permeate and retentate. The retentate generated in 
the membranes is recirculated to the initial solution while the permeate of the last 
membrane is being constantly collected. The volume of each cell was about 30mL and 
the volume of the feed solution was 60mL. Therefore the total volume of the system, 
which corresponds to 1 vol, is 120mL with the first stage 90mL (feed tank and the first 
cell), while the second stage corresponds only to the second cell of 30mL This 
configuration operates in closed mode with permeate of the second stage being 
recirculated to the feed tank maintaining the feed tank volume constant. In this 
configuration the cells have a magnetic stirrer to maintain the homogeneity of the system. 
The HPLC pump had a flow rate of 50ml/min.  
 
 
 
Figure 20. Schematic representation of the cascade membrane process integrating a cascade of 
2 membrane units for purification. 
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3.4.3. Diafiltration configuration and modelling 
To improve the separation of this pressure driven process and increase the yield 
and the purity, a diafiltration configuration can be applied, by constantly adding new 
solvent. The membrane diafiltration configuration, Figure 21, is similar to the cascade 
configuration, with the difference that in this case we introduce fresh solvent in the feed 
tank to maintain the volume of the system constant. This fresh solvent is introduced at 
the same rate that the permeate is being discharged in a vessel.  
 
 
 
 
 
Figure 21. Schematic representation of the diafiltration membrane process integrating two 
membrane units for purification. 
For the first configuration, Figure 21, the volume of each cell was about 30mL 
and the volume of the feed solution was 60mL. Therefore the total volume of the system, 
which corresponds to 1 vol, is 120mL, with the first stage 90mL, for the feed tank and 
the first cell while the second stage corresponds only to the second cell of 30mL. The 
HPLC pump had a flow rate of 50ml/min. 
If the results obtained using the configuration above are not satisfactory a 
different configuration with pumps providing mixing in the system and enhancing mass 
transfer, can be used, Figure 22. In this case the total volume of the system equivalent 
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to 1 vol corresponds to 195 mL, 75mL from the feed tank, and 60mL each cell. The first 
stage corresponds to the fed tank and the first cell, 135mL, while the second stage is 
just the second cell, 60mL. The HPLC pump had a flow rate of 50ml/min. 
 
 
 
 
Figure 22. Schematic representation of the diafiltration membrane process integrating a cascade 
of two membrane units for purification. 
 
In both configurations, only the feed solution of the first stage is rich in the 
component with highest rejection.  
The simulations were carried out in MATLAB®, using the function ode45 and are 
an extension of a single stage membrane mass balance for both stages of the system to 
each component of the mixture that we pretend to separate, Equation 11. The model 
requires the variables permeance, rejection, the volumes of the tanks and the area, 
Annexe0. In the case of cascade simulation the variables were the experimental values 
obtained from the single screening for each membrane. Even though different scenarios 
were simulated, only the best four were tested experimentally. The variables for the 
diafiltration simulation were obtained from the four experimental cascade screening. The 
model assumes that the system is closed and no mass is lost and therefore the system 
operate at constant volume. The feed concentrations are 1.5 g.L-1 for PEG2000 and 1 
g.L-1 for PEG8000 and PEG20000 and these components don’t go under reactions once 
they are introduced in the cascade system.   
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𝑉 
𝑑𝐶𝑅,𝑖
𝑑𝑡
=  − 𝐹 ∗  𝐶𝑝,𝑖 =  𝐽𝑣 ∗ 𝐴 ∗  𝐶𝑝,𝑖 Equation 11. Mass balance to diafiltration 
 
By definition the observed rejection of species i is, 
𝑅𝑜𝑏𝑠 = 1 −  
𝐶𝑝,𝑖
𝐶𝑅,𝑖
 Equation 12. Observed Rejection 
And therefore the concentration profile for a single stage can be defined as  
𝑑𝐶𝑅,𝑖
𝑑𝑡
=  − ( 
1
𝑉
) ∗  𝐽𝑣 ∗ 𝐴 ∗ 𝐶𝑅,𝑖 ∗ (1 − 𝑅𝑜𝑏𝑠) Equation 13. Concentration Profile 
When the system is developed for the diafiltration two- stage membrane, the 
following four differential equations are be obtained, Equation 14, Equation 15, Equation 
16 and Equation 17. 
𝑑𝐶𝑅1,𝑖
𝑑𝑡
=  
1
𝑉1
∗ [− 𝐹1 ∗  𝐶𝑅1,𝑖 ∗ (1 − 𝑅1,𝑖) + 𝐹3 ∗  𝐶𝑅2,𝑖  ] 
Equation 14. Concentration 
gradient of stage 1 for 
species i 
 
𝑑𝐶𝑅2,𝑖
𝑑𝑡
=  
1
𝑉2
∗ [ 𝐹1 ∗  𝐶𝑅1,𝑖 ∗ (1 − 𝑅1,𝑖) − 𝐹2 ∗  𝐶𝑅2,𝑖 ∗ (1 − 𝑅2,𝑖) − 𝐹3 ∗  𝐶𝑅2,𝑖   ] 
Equation 15. Concentration 
gradient of stage 2 for 
species i 
𝑑𝐶𝑅1,𝑗
𝑑𝑡
=  
1
𝑉1
∗ [− 𝐹1 ∗  𝐶𝑅1,𝑗 ∗ (1 − 𝑅1,𝑗) + 𝐹3 ∗  𝐶𝑅2,𝑗 ] 
Equation 16. Concentration 
gradient of stage 1 for 
species j 
 
𝑑𝐶𝑅2,𝑗
𝑑𝑡
=  
1
𝑉2
∗ [ 𝐹1 ∗  𝐶𝑅1,𝑗 ∗ (1 − 𝑅1,𝑗) − 𝐹2 ∗  𝐶𝑅2,𝑗 ∗ (1 − 𝑅2,𝑗) −  𝐹3 ∗  𝐶𝑅2,𝑗   ] 
Equation 17. Concentration 
gradient of stage 2 for 
species j 
 
where i and j refer to the different species in solution to be separated. These equations 
will gives us four different columns of concentration. These four columns have m rows, 
depending on the time interval, defined as tspan.  
F2 and F3 , Equation 18, depend on the recycle ratio, Equation 19, which is an 
independent variable that can be controlled depending on the flow we want for the 
permeate and for the retentate. 
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F1 = F2+ F3  Equation 18. System flow rate balance 
  
rc =  
F3
F1
  Equation 19. Recycle ratio 
    
The yield and the purity profiles are obtained from the concentrations profiles of 
the differential equations.  In the study case the product is the compound with highest 
rejection, the PEG8000 and PEG20000, hence the yield, Equation 20, and purity, 
Equation 21 are calculated considering the first stage only.  
𝜇𝑃(%) =
𝐶𝑅1,𝑖 ∗  𝑉1
𝐶𝐹𝑖,0 ∗  𝑉𝐹
∗ 100 
Equation 20. Yield of the product in the 
first stage 
𝑃𝑃(%) =
𝐶𝑅1,𝑖
∑ 𝐶𝑅1,𝑖
∗ 100 
Equation 21. Purity of the product in the 
first stage 
   
Where 𝐶𝑅1,𝑖 is the concentration of component in the first stage, 𝐶𝐹𝑖,0 is the initial 
concentration of component in feed tank, 𝑉1 is the volume of stage 1, while 𝑉2 is the 
volume of stage 2 and 𝑉𝐹 is the volume of the feed tank. The stage 1 is always the feed 
tank and the first cell while the second stage is only the second cell. The accuracy of the 
model created was proven using the conditions presented in the paper “When the 
membrane is not enough: A simplified membrane cascade using OSN” by Jeong F. Kim 
et al. Once the model was verified, it was also assumed that the fluxes and the rejections 
are constant throughout the operation and therefore the rejections and fluxes used were 
the average of the results. 
 
3.5. Analytical method: High Performance Liquid Chromatography (HPLC)  
In all the configurations rigs, the samples of permeate and retentate were 
analysed by Agilent 1100 Series HPLC system. Nowadays most of the High-
Performance Liquid Chromatography (HPLC) separation columns work with an 
Evaporative Light Scattering Detector (ELSD) compared with Refractive Index (RI) 
detectors. The main goal of using an ELSD is that it detects samples that don’t absorve 
UV light, like the PEGs. The principle of an ELSD is that the conversion of the eluents to 
a fine spray via a nebulizer, using nitrogen has the inert carrier gas. The ELSD analysis 
consists of the following three steps: nebulization, mobile-phase evaporation and 
detection. In the nebulisation, the nitrogen will flow through the effluent column in order 
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to form an aerosol. The nitrogen will afterwards be used in the mobile-phase evaporation 
which is heated allowing the evaporation of the mobile-phase. The final phase, the 
detection, is achieve by excitation of photons of the evaporated particles. (Dolan, 2003)  
The reverse phase column (V14-8046, 250mmx4.6mm, ACE UltraCore 5 
SuperC18) was used with the mobile phase A2 and B2 prepared in 2.5L flasks. Solvent 
A2 was a buffer of 0.97g of ammonium acetate in 2.5L of water (5mM) while solvent B2 
was a solution of 80:20 of acetonitrile: methanol, respectively. The total flow was 1
ml
min
 , 
10% A2 (0.1
ml
min
) and 90% B2 (0.9
ml
min
 ). In this chromatography the grade solvent used 
was acetonitrile (ACN), due to the fact that this solvent has lower absorvance, about 190 
nm, which makes it the best choice for molecules that don’t absorve UV light, like the 
PEGs. (Waters , 2019) For over 30 minutes, 30µl of elute collected sample were 
analysed and as a result, chromatograms like the one in Figure 23 were obtained. The 
identification of PEGs MW for each sample was based on the retention time (RT) of the 
PEGs’ standard solutions (1g/L), Annexe. Table 9 presents the retention times of 
standard solutions.  
 
Table 9. Retention Time of PEGs’ Standard Solutions 
Standard PEG solution Retention Time (min) Signal Area 
PEG400 10.14 203.31 
PEG1000 13.32 240.1 
PEG2000 15.68 248.6 
PEG8000 18.66 605.3 
PEG20000 19.60 1204.2 
 
It is possible to observe that the smaller the component analysed, the faster the 
elution, therefore the PEG400 signal is eluted first than PEG20000. In order to know the 
rejection it was assumed that the concentration ratio is proportional to the area ratio of 
the corresponding peaks. 
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From Figure 23 it is verified that lower MW PEG have shorter RT, which is 
expected since lower MW PEGs with longer non-polar chains tend to be less strongly 
adsorbed to the column.   
 
A 
 
 
B 
 
Figure 23. Example of an ELSD detector curve for PEG solution (400, 1000, 2000, 8000 and 20k 
DA) (1g/L) (A) without integration, (B) with area integration considering the RT presented in  
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3.5.1. HPLC calibration 
To calculate the purity and the yield it was necessary to convert the HPLC peak 
areas to concentration and mass. For that it was necessary to calibrate the HPLC. A 
solution of 1g/L in 100mL of PEG2000, PEG8000, PEG20000 was prepared and then 
diluted in 16 solution in 20mL flasks, with concentrations (g/L) of 0.01, 0.02, 0.025, 0.05, 
0.1, 0.15, 0.2, 0.25, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1. The calibration curve is presented 
in Figure 24.  
 
 
 
 
Figure 24. HPLC calibration curve. 
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3.6. Membrane Morphology- SEM  
SEM images are a useful tool for the characterization of the membrane 
properties. One of the advantages of SEM is that it gives information about the functional 
performance of the membranes and allows their structural characterization. The cross-
section was broken in liquid nitrogen and placed vertically in the stubs while the 
horizontal sample was simply cut at room temperature and placed horizontally on the 
stubs. Due to the fact that polymeric membranes are non-conducting, the samples of the 
membranes were coated with 15 nm of chromium using a sputter coater Q150T S 
(Quorum Technologies Ltd). A Field Emission Scanning Electron Microscope was used 
to acquire the high resolution SEM images with an accelerating voltage of 5 kV and under 
dry conditions at room temperature. 
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4 .  Results and Discussion 
4.1. Single membrane Screening   
In order to select a membrane that is able to separate PEG2000 (MW= 2000 
g.mol-1) from larger PEGs. In order for this to happen, the OSN membrane needs a 
rejection close to 100% to intermediate oligomers with 8000Da and larger and the 
minimum rejection possible for oligomers of 2000Daand lower. Samples of permeate 
and retentate were taken and analysed in the HPLC and was compared with the standard 
samples (1g/L), Figure 23 B), Chapter 3.5. 
The results presented in this chapter are average of the two membranes and 
permeates obtained during the single screening for PEG400, PEG1000, PEG2000, 
PEG8000 and PEG20000 using different membranes.  
Figure 25 A) and B) it is possible to see that all the PEEK membranes have a 
rejection above 70% to all PEG MW, hence the membrane is too tight and even 400 Da 
molecules cannot pass through the membrane. The PEEK_80ºC have higher average 
rejection than PEEK_50ºC. PEG1000, PEG2000, PEG8000 and PEG20000 have similar 
rejections at 5 bar, 10 bar or 20bar. In all PEEK membranes the rejection for PEG1000 
and larger intermediate oligomers is above 90%, therefore PEEK membranes cannot 
separate molecules with MW in the range 1000- 20000 Da. The experiments were not 
repeated, therefore the results are inaccurate, in order to decrease the error and have 
more accurate results the experiments should have been repeated. 
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A 
 
 
B 
 
Figure 25. MWCO curve for A) PEEK_50ºC membranes in single screening and 
B) PEEK_80ºC membranes in single screening. 
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Due to the fact that PEEK membranes prove to not separate molecules with MW 
smaller than 2000 from molecules with MW large than 8000, these membranes were not 
used in the further studies with cascade and diafiltration configurations.  
From Figure 26 B) and D) it is possible to see the different membrane composition 
typical of ISA membranes, Figure 17. In this case the toplayer (0.1- 0.5 μm of thickness) 
composed of smaller pores offers more resistance to mass transference than the 
sublayer composed of particles with larger pores (50-150 μm of thickness) that offer 
mechanical support to the toplayer. PEEK50ºC, Figure 26 A), is tighter than the 
PEEK80ºC, Figure 26 C), giving us the trend that the lower the temperatures in which 
the membrane were left to dry the tighter the pores. (Burgal, 2016) Another way of 
comparing pore size that doesn’t involve SEM images is by measuring the permeability 
with pure solvent for a period of 24h and applying the same transmembrane pressure 
conditions to all the membranes. In most of the cases the membranes with higher 
permeability have bigger pores while the ones with smaller permeability have smaller 
pores. 
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A B 
  
C D 
  
Figure 26. SEM image of membranes. (A) Top-section view of PEEK 50ºC at 100000x 
magnification; (B) Cross-section view of PEEK 50ºC at 1000x magnification; (C) Top-section view 
of PEEK 80ºC at 100000x magnification; (D) Cross-section view of PEEK 80ºC at 1000x 
magnification. 
Regarding PBI, Figure 27, both membranes have less than 10% of average 
rejection for PEG400. Still in PBI18m5j2005 the PEG1000 and PEG2000 increase the 
rejection to about 82%. For this same membrane, PEG8000 and PEG20000 have a 
rejection of 97% and 99%, respectively. Therefore the PBI18m5j2005 membrane is not 
suitable for the separation of PEG1000 and PEG2000 from PEG8000 and PEG20000. 
In the case of PBI18j1000, the greatest difference from the former is that PEG400 as 6% 
rejection and for PEG1000 the average rejection is 51%. PEG2000 has a rejection of 
78%, while PEG8000 and PEG20000 have better average rejection than the former PBI 
membrane, almost 100%. The negative rejection may be due to the HPLC calibration. 
The calibration curves were fitted as linear with a square error of the regression line 
between 86-95%. A polynomial curve, would fit the data better and therefore would have 
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diminished the errors of the regression line and could have avoided the negative values 
of rejection. For the same reason as mentioned before, the experience should be 
repeated in order to decrease the error and the experiment be considered reproducible.  
 
 
Figure 27. MWCO of PBI membranes in single screening. 
Figure 28 presents the same data of PDA2gL_18h membrane and tested at 
different pressures to understand the effect of pressure in rejection.  
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Figure 28. MWCO curve for the single screening of PDA membraes tested at different presures. 
For the same MW at different pressures, the increase in pressure leads to a 
decrease in rejection for particles larger than 2000Da. Meaning that membrane tested at 
15 bar achieves a maximum rejection of ~80%, while the one tested at 5 bar achieves a 
rejection of 96%. Considering that the goal is to have a rejection close to 100% for PEG 
8000 and PEG20k, and the minimum for PEG2000 and smaller, lower pressure 
conditions are more adequate than higher. This phenomenon of increasing the pressure 
leads to a decrease in rejection is predicted by the gel polarization model. The model 
states that the increase in pressure leads to an increase in flux, which leads to an 
increase of convective transport of solutes through the membrane. When the 
concentration of solutes being transported increases, they start to accumulate near the 
surface, until the back diffusive mass transport equals the convective transport. This 
gradient concentration removes solute from the membrane, leading to a decrease of 
PEG8000 and PEG20k retention. (Zambujo Pé-Leve, 2012) (N.M. D’Souza, 2003) For 
MW smaller than 2000Da the PDA2gL membrane presents an irregular behaviour with 
rejection being independent from the pressure. The polydopamine didn’t dissolve 
properly and the undissolved particles blocked the pores. Due to that, the PEG solution 
is more retained by the membrane with a coating of 18h and so the rejection is higher 
than when the membrane was coated for 48h. In the coating for 48h the polydopamine 
dissolved and therefore there was no obstruction of pores to the passage of solute and 
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more PEG2000 were able to cross the membrane, but also bigger PEGs where able to 
cross some of the membrane pores. 
 Figure 29 presents the data of the PDA2gL membrane prepared with the method 
of Chapter 3. In this case, the PDA 2gL_30h and PDA2gL48h have rejections for 
PEG2000 of 46.29% and 36.46% respectively. PEG8000 and PEG20000 have rejections 
in the range of 70-80%. While PDA 2gL_18h has rejection for PEG2000 of 69.61% and 
87.27% and 88.62% for PEG8000 and PEG20000, respectively. According to the 
literature the membranes with higher coating time should be ticker, hence have higher 
rejection, but only PEG1000 has the expected behaviour, i.e., the more the time the PE 
membrane was in the solution with polydopamine the tighter membrane pores are and 
therefore the rejection increases from 18h to 30h and to 48h. Hence there isn’t a verified 
trend between MW and rejection for MW below 2000Da. For PEG2000, PEG8000 and 
PEG20000 the opposite was verified with the average rejection decreasing with the 
increasing of time in the polydopamine solution. In 18h the polydopamine didn’t dissolve 
properly and the undissolved particles blocked the pores, Figure 30. Due to that, the 
PEG solution is more retained by the membrane with a coating of 18h and so the 
rejection is higher than when the membrane was coated for 48h. In the coating for 48h 
the polydopamine dissolved and therefore there was no obstruction of pores to the 
passage of solute and more PEG2000 were able to cross the membrane, but also bigger 
PEGs where able to cross some of the membrane pores.  
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Figure 29. MWCO curve for the single screening of PDA_2gL membranes tested at different 
coating times. 
 
 
The morphology of the PDA2gL membranes prepared in the lab is presented in 
Figure 30. It is perceptible that the more time the membrane was in solution the ticker 
the membrane fibres get. The small white particles seen, are undissolved polydopamine. 
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Figure 30. SEM images of membranes. (A) Top-section view of PDA 2gL for 18h at 50000x 
magnification; (B) Top-section view of PDA 2gL for 30h at 50000x magnification; (C) Top-section 
view of PDA 2gL for 48h at 50000x magnification. 
Concerning PDA4gL, Figure 31, the results are unexpected due to the fact that the 
PDA48h_4gL membrane was coated for a longer period, therefore, should be tighter and 
have higher rejection than PDA30h_4gL. One reason can be the fact that because the 
polydopamine was in higher concentration it couldn’t dissolve well in 30h and it blocked 
some of the pores of the membrane, while the 48h dissolved better in the surface and 
didn’t block the pores. Hence in the 30h coating the retention of bigger PEGs but also of 
smaller PEGs is higher than the one verified in 48h coating. The rejections are around 
60%, 80%, 85% and 90% for PEG1000, PEG2000, PEG8000 and PEG20000, 
respectively. Therefore the membranes coated with 4gL of polydopamine are not suitable 
for this studied and were not used in further experiments. 
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Figure 31. MWCO curve for the single screening of PDA_4gL membranes tested at different 
coating times. 
 
The SEM images of PDA 4gL 30h and 48h are presented in Figure 32 A and 
Figure 32 B respectively. As for the PDA 2gL, for the PDA 4gL the more time the 
membrane was in solution, the better the coating. Hence the PDA4gL coated for 30h has 
bigger pores than the membrane PDA4gL coated for 48h. But also has it is seen there 
is much more polydopamine undissolved in the membrane coated for 30h, Figure 32A, 
than for the membrane coated for 48h, Figure 32B. This can result in interactions 
between the PDA undissolved and the PEG solution or the PDA blocking the inner pores 
of the membrane obstructing the passage of PEG and causing an unexpected higher 
rejection in the PDA 30h than in the PDA 48h. 
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A B 
  
Figure 32. SEM images of membranes. (A) Top- section view of PDA 4gL for 30h at 50000x 
magnification; (B) Top-section view of PDA 4gL for 48h at 50000x magnification  
 
In general, for most membranes, the rejections reach a steady-state after 3 hours. 
The results of Table 10 show that in the majority of the membranes, after the stabilization 
the rejections either maintain or increase due to the membrane compaction, hence at 
24h, the membrane is at its highest compaction level. This effect is particularly present 
in looser membranes (See-Toh., 2008). The most stable membranes are PBIm5j2005 
and PEEK. The rejections of PBIj1000 seem to not have stabilized after the usual 3 
hours. The membranes coated with PDA also have a higher variation of the rejection 
when compared with the variation of the PEEK or PBIm5j2005. Nevertheless in most of 
the cases the rejection after 24h increases which also indicates higher compaction of the 
membranes (Gibbins, 2002). 
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Table 10. Rejections after 3h and 24h for the single screening 
 
 
Figure 33 presents the results of the permeance of all membranes tested in a 
single screening. Except for PBIm5j2005, PEEK80ºC_5bar and PEEK80ºC_20bar, all 
the membranes have a decrease in permeance. This decrease is associated with the 
previously explained pores compaction or with the concentration polarization and 
membrane fouling that will cause a decrease in the driving force and an increase in 
resistance near the membrane wall. Hence the greater the permeance decrease, the 
greater concentration polarization and fouling effect. One way to prevent this initial 
permeance decline was, before the experiments with the PEG solution start, do a 
preliminary membrane compaction running pure solvent at a highest transmembrane 
pressure and then induce a stepwise decrease of the same, instead of running pure 
solvent only for 2h at a constant transmembrane pressure. (Droli, 2014) Usually, after 5 
hours the permeance flux tends to achieve a steady-state mode until the end of the 
experiment. PDA5bar and PDA2gL_18h present a constant decrease in the permeance 
and didn’t reach the steady-state within 24h. The decrease in permeance was more 
significant for PEEK_50ºC_5bar, PEEK50ºC_20bar, PDA2gL_48h and PDA4gL_48h, 
attributed to membrane compaction. In the case of the PBIm5j2005, PEEK80ºC_5bar 
and PEEK80ºC_20bar the permeance increased in the first 3 hours and then achieved 
the steady-state. As expected from the rejection results, PEEK membranes have the 
3h 24h 3h 24h 3h 24h
PBIm5j2005 90.97 90.28 95.15 97.43 98.75 99.26
PBIj1000 73.53 82.29 96.55 99.33 97.60 99.48
PEEK50_5bar 91.50 93.24 98.92 99.33 99.58 99.77
PEEK50_10bar 92.69 91.59 97.75 96.55 99.50 99.58
PEEK50_20bar 94.05 94.02 98.18 98.40 99.46 99.78
PEEK80_5bar 92.84 94.81 99.33 99.44 99.68 99.83
PEEK80_10bar 93.15 80.81 99.48 95.52 99.75 99.03
PEEK80_20bar 95.03 95.94 98.58 98.93 99.60 99.72
PDA2gL_18h_5bar 58.54 66.90 89.80 93.22 95.72 97.41
PDA2gL_18h_10bar 68.36 67.48 86.85 88.85 90.36 94.95
PDA2gL_18h_15bar 69.99 56.84 82.92 88.73 88.08 93.69
PDA2gL_18h 67.55 72.15 83.88 94.95 82.05 97.17
PDA2gL_30h 46.79 52.99 84.28 89.37 86.19 92.88
PDA2gL_48h 45.70 32.25 62.04 84.80 81.17 89.56
PDA4gL_30h 87.31 82.85 94.89 94.25 97.75 98.48
PDA4gL_48h 76.17 82.75 82.47 82.47 93.50 97.64
R20000(%)
Rejections (%)
Membrane code R2000(%) R8000(%)
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highest fluxes due to their looser pores. PEEK50ºC at 5 bar have higher standard 
deviation since one of the discs is more permeable than the other. On the other hand, 
PBIm5j2005 is very uniform and the results very consistent with the smallest standard 
deviations of all experiments. The membranes dried from water at 80 °C have higher 
permeance than the membranes dried at 50 °C because at 80ºC they are looser. (João 
da Silva Burgal L. P., 2015) In the case of PDA membrane tested at different pressures, 
the increasing applied pressure, the driving force of the system, lead to a decrease in 
the flux. Therefore according to the gel polarization model, the decrease in flux can be 
attributed to the increase of resistance to the membrane transport and pore shrinkage 
(N.M. D’Souza, 2003). 
 
 
 
Figure 33. Permeance results of the all the membranes tested in the single screening filtration 
mode  
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From the single screening tests, the membranes more adequate to proceed for 
the cascade membranes are PDA2g/L and PBI, while PDA4g/L and PEEK were not 
further studied. 
 
 
4.2. Cascade Screening 
In order to improve the separation of the single stage membranes, the cascade 
configuration was applied. The goal of the cascade diafiltration is to select the best set 
of membranes able to separate PEG2000 (MW= 2000 g.mol-1) from larger PEGs. Hence 
the OSN membrane needs a rejection close to 100% to intermediate oligomers with 
8000Da and larger and the minimum rejection possible for oligomers of 2000Da and 
lower. The samples were taken and tested in the HPLC for 24 hours. The new 
configuration (Figure 20, Chapter 3.4.2) has two permeate samples and two retentates 
which were collected and compared with the standard samples. The set of membranes 
tested, presented in Table 11, were chosen considering the rejections obtained in the 
single screening configuration and the model prediction, Chapter 3.4.3. Due to pressure 
drop from the first stage to the second stage, the second stage needs to have a lower 
transmembrane pressure than the first stage. 
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Table 11. Set of membranes tested in cascade mode 
Cascade mode Stage 1 Stage 2 
Experiment 1 
Membrane code PBIj1000 PDA_2gL_30h 
Transmembrane 
Pressure (bar) 
20 10 
Experiment 2 
Membrane code PBIj1000 PDA_2gL_30h 
Transmembrane 
Pressure (bar) 
30 10 
Experiment 3 
Membrane code PDA_2gL_30h PDA_2gL_30h 
Transmembrane 
Pressure (bar) 
10 5 
Experiment 4 
Membrane code PDA_2gL_30h PBIj1000 
Transmembrane 
Pressure (bar) 
20 10 
 
 Experiments 3 and 4 were repeated twice, while experiments 1 and 2 due to the 
low value of flux throughout the experiment were not repeated. In this case the solution 
is composed of PEG2000, PEG8000 and PEG20000 in the ratio 1.5:1:1 in THF- to 
simulate the conditions expected after completion of fragment condensation reaction. 
Figure 34 shows the rejection profile for each membrane tested in the cascade screening 
for both stages, in which p1 refers to stage 1 and p2 refers to stage 2 (see Figure 20, 
Chapter 3.4.2)  
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Figure 34. MWCO curve for the cascade screening tests experiments 1 and 2. 
The first experiment, Figure 34, cascade both stages present a similar rejection to 
the solution. The first stage has a rejection of about 97-98% for all PEGs while the second 
stage has a rejection of 82%, 84% and 91% for PEG2000, PEG8000 and PEG20000, 
respectively. Therefore neither stage was able to have a good separation of PEG2000 
from PEG8000 and PEG20000. The permeance, Figure 35, in this experiment was also 
too low for stage1 and was kept constant, due to the fact that PBI membranes are very 
stable. While the stage 2 with PDA membrane suffered a decrease in permeance from 
32 L/m2.bar-1.h-1 to 10 L/m2.bar-1.h-1 due to membrane compaction. In order to increase 
the flux and to improve the separation of PEG2000 from PEG8000 and PEG20000, it 
was necessary to increase the pressure of the first-stage. After the pressure modification, 
as expected and from Figure 35, the increase in pressure lead to an increase in flux. 
Although the flux increased in the second cascade experiment, the membrane of 
the first stage in too tight and rejects every MW PEG, Figure 34. However, the second 
stage has a better separation than the previous experiment, with a rejection of 69% for 
PEG2000 and around 98% for PEG8000 and PEG20000. This improvement of the 
membrane in the second stage is more notorious in the first two hours, with a rejection 
of 40% for PEG2000 and above 95% for the remaining PEGs. But after the 3rd hour, the 
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membrane suffers sudden compaction, becomes too tight and starts rejecting 90% 
PEG2000. In this experiment, the flux decreased constantly with the permeance of the 
first stage lower than the second stage. 
 
 
 
 
Figure 35. Permeance of the first two experiment cascade screening tests. 
 
  
The third cascade experiment was repeated twice and the results are not consistent 
regarding the second stage. The first stage membrane is too tight and rejects 89% of 
PEG2000 and has a rejection above 95% for PEG8000 and PEG20000. The second 
stage membrane had an average rejection of 64% for PEG2000, 74% and 79% for 
PEG8000 and PEG20000, respectively, Figure 36. 
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Figure 36. MWCO curve for the cascade screening tests experiments 3 and 4. 
The inaccurate results and high errors for the second stage are due to the fact 
that in the first trial, the second membrane rejected 80% PEG2000 and 90% above for 
the remaining PEGs, while for the second trial the rejection of the second stage for 
PEG2000, PEG8000 and PEG20000 was of 50%, 66% and 74%, respectively. This 
inconsistency may be an indication of the non-uniformity of the polydopamine membrane 
coating. Another difference in the experiments for the second stage is the fact that for 
the first trial, the rejection started in 37% for PEG2000, 63% for PEG8000 and 80% for 
PEG20000. In the third hour, quick compaction of the membrane leads to an increase of 
rejection, 72% for PEG2000, 89% for PEG8000 and 93% for PEG20000 that increased 
to 98% for all PEGs after 14h. The permeance of the second stage, Figure 37, is higher 
than the one of the first stage, still, after the third hour, it suffers a decrease for both 
stages in the first trial. In the second trial, the first stage rejected everything while the 
second stage rejected 50%, 66% and 74% for PEG2000, PEG8000 and PEG20000. 
Although the pressure was the same in both experiments, the second trial has average 
permeance 33% lower than the ones obtained for the second stage due to the non-
uniformity of the PDA membranes. 
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The last cascade experiment was also repeated twice and the results are not 
consistent with the second trial results being closer to the expected. In this trial, the first 
membrane rejected 78% for PEG2000 and about 90% for the remaining PEGs, while the 
second stage has a rejection of 50% for PEG2000 and above 90% for PEG8000 and 
PEG20000. The first stage has an initial decrease from 0.12 L/h to 0.08 L/h but then it 
rises again to the initial value. The second stage has an increase from 0.07 L/h to 0.09 
L/h, but afterwards, it has a sudden decrease to 0.03L/h. The permeance has the same 
behaviour has the flux in both stages. 
 
 
Figure 37. Permeance of the last two experimenrts of cascade screening tests, each exeriment 
was repeated twice 
Afterwards, the cascade results show that the best combination of membranes 
for rejection is experiment 4 with PDA at 20 bar in the first stage and PBIj1000 at 10 bar 
for the second stage.  
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4.3. Diafiltration Screening 
This chapter presents the results of both configurations of diafiltration, (see Figure 
21 and Figure 22 in Chapter 3.4.3). For both cases PEG8000 represents the simulation 
of the first coupling, in which the total peptide structure would have around 8000Da while 
the PEG20000 corresponds to the second fragment coupling in which the peptide 
structure would have 20000Da while the fragments always have around 1.5-2k Da. 
 
4.3.1. First configuration 
In the first diafiltration configuration, although the volume of each cell was about 
15.5mL, the volume of each stage was 30 mL while the volume of the feed solution was 
60mL. Therefore the total volume of the system, which corresponds to 1 vol, is 120 mL 
with the first stage 90mL and the second stage 30mL. Just as in the cascade, the PEG 
solution had a concentration of concentration (g/L) of 1.5:1:1 for 
PEG2000:PEG8000:PEG20000.  Figure 38 and Figure 39 show the results for the purity 
and yield obtained in the diafiltration process for PEG8000 and PEG20000 using the 
configuration of Figure 21 (Chapter 3.4.3). This configuration required the addiction of 
0.720L of pure THF. As it can be seen for PEG8000, Figure 38, the model predicted a 
starting purity of 40% while the experimental purity is 60%. One of the causes can be 
the accuracy of measuring, in both cases overweighting. After 6 vols all the feed solution 
had been washed out and the purity reached 90% as predicted by the model. On the 
other hand, the final yield is only 10%, while the prediction was of 40%. This low yield 
may be due to mass transfer problems. 
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Figure 38. Calculated and experimental purity and yield for PEG8000. 
For the PEG20000, Figure 39, the purity predictions fit in the experimental 
results. The yield should have reached 70% after 6 vols according to the model, but the 
experiments show a huge drop and after 6 vols is less than 10%. 
 
 
 
Figure 39. Calculated and experimental purity and yield for PEG20000. 
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During this experiment it was verified precipitation of PEG inside the membrane 
cell, Figure 40, that may have led to low mass transference hence low yield.  
 
 
Figure 40. PEG precipitation 
4.3.2. Second configuration 
The new configuration, Figure 22 Chapter 3.4.3, has two pumps to promote 
mixing and circulation of the liquid in order to increase the mass transference and 
therefore the yield obtained. PEG precipitation was not verified. In this case, the volume 
of each stage was 60 mL while the volume of the feed solution was 75mL. Therefore the 
total volume of the system, which corresponds to 1 vol, is 195 mL with the first stage 
135mL and the second stage 60mL. As previously, the PEG solution had a concentration 
of concentration (g/L) of 1.5:1:1 for PEG2000:PEG8000:PEG20000. Figure 41 and 
Figure 42 show the results for the purity and yield obtained in the diafiltration process for 
PEG8000 and PEG20000 using the configuration of Figure 21, Chapter 3.4.3. For this 
configuration, 6 vols required the addiction of 1.170L of pure THF, half litter more than 
the previous diafiltration. This time the initial experimental purity matches the model 
prediction for both PEG8000 and PEG20000. Unexpectedly after 6 vols the experimental 
yield reached 30% while the model predicted 95%. Due to this discrepancy and the 
amount of solvent required the experiment was stopped. Even though the experimental 
yield is 60% lower than the model prediction, the purity was only 10% underestimated 
by the model. Hence after 6 vols, the experimental purity is 60% while the model 
predicted 50%. 
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Figure 41. Calculated and experimental purity and yield for PEG8000. 
 
Similar behaviour is verified for the PEG20000 with the model prediction of 60% 
and 95% for purity and yield respectively after 6 vols, while the experiments show the 
purity is 70% and the yield is 40%. 
 
Figure 42. Calculated and experimental purity and yield for PEG20000 
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To understand the mass transfer in both configurations, it was necessary to 
calculate the Reynolds number. The diameter of the impeller is 3 cm and the agitation 
speed was 500rpm (rotations per minute). The Reynolds number is the first configuration 
depends on the diameter and speed velocity of the stirrer and on the density and viscosity 
of the solution. It was used the data of THF instead of the solution. In the second 
configuration, the Reynolds number on the entry port of the cell depends on the diameter 
of the tube which was ¼ inch, on the speed of permeate which depends on the area of 
the tube and the flow of the pump. The pump operated at 20% of its total power, therefore 
considering Figure 43 present in Annexe 0, the flow rate, Q, is approximately 90 L/h. The 
viscosity and density were assumed to be the viscosity and density of THF. (DDBST 
GmbH, 2019) The results of the dimensionless numbers for the analysis of mass 
transference are presented in Table 12. 
Table 12. Dimensionless Numbers 
Configuration Dimensionless number Region 
1st diafiltration 
Re 8813.66 Turbulent 
Np 4.00 -------------- 
P (W) 0.01 -------------- 
2nd diafiltration Re 9817.93 Turbulent 
 
 
 According to the calculations both configurations have turbulent flow, still the fact 
that the values for viscosity and density were approximate the results are not accurate. 
Reynolds for the first configuration is 8k while the second diafiltration has a Reynolds of 
about 10k which means that the flow is turbulent. As expected the first configuration has 
more mass transfer problems than the 2nd configuration proved by its lower Reynolds 
number indicating the viscosity of the fluid has larger impact than the density of the fluid. 
Considering that the stirrer can be approximate to a Straight-blade turbine, according to 
Figure 3 Chapter 2.1.2 considering curve 2, the power number is 4, which corresponds 
to an impeller power of 0.011 Watts.  
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5 . Conclusions and future work 
This work proposed the integration of a membrane cascade as well as diafiltration 
process to improve the separation performance realized by a single membrane in the 
purification of peptides. As a case study it was used a solution of containing oligomers  
of different MW that match the MW of the peptides, sizing 8000Da and 20000Da, by-
products and impurities, of size 2000Da. This approximation simulates the MW of the 
fragments and by-products of reaction, but it doesn’t take in consideration the fact that 
amino acids tend to have a lot of interactions with the medium they are being prepared 
in. Hence the results are not accurate for a real life application and the aminoacids and 
fragments would interact with the membrane and most likely decrease the rejection. 
The single screening configuration tested different membranes in different 
pressure conditions membranes, including PBI, PEEK and membranes coated with 2g/L 
and 4g/L polydopamine. The results showed that neither of the PEEK membranes, 
neither the coating with 4g/L of polydopamine could separate the PEG2000 from larger 
PEGs, hence these membranes were not further studied. 
Using the MATLAB simulations and the results of single screening it was possible 
to predict that from the remaining membranes, the best combinations would be using 
PBI and 2g/L of polydopamine. The experimental results showed that PDA2g/L_30h at 
20 bar in the first stage and PBIj1000 at 10 bar for the second stage have the best 
separation, with the second stage rejecting about 95% PEG8000 and PEG20000, and 
68% PEG2000. These membranes were applied in the diafiltration mode in the same 
above conditions. 
For the first diafiltration configuration, the MATLAB simulations predicted yields 
between 40-70% and purities above 90% after 6 vols, but the experimental results don’t 
fit in the predictions with yields below 10% after 6 vols. The second diafiltration 
configuration improved the experimental yield results to 30-40% because the mass 
transference was improved by placing pumps in each cell instead of a magnetic stirrer, 
but still, the model predicted yields above 90%. The experimental purity was around 60-
70%, which is 10% overestimation according to the model.  
According to the literature, the diafiltration is a process that increases the 
purification of the APIs, but it was concluded that the diafiltration performance also 
depends on the membranes selected. On the contrary to the membranes studied, for the 
purification be efficient, the membranes should have had a rejection close to 100% for 
PEG8000 and PEG20k, but they should have the minimum rejection possible, preferably 
close to 0% for PEG2000 and lower, in order to have complete separation. Hence to 
better purify the necessary APIs, different membranes must be developed and studied. 
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7. 7.  Annexes 
7.1 Matlab Code used for the Cascade and diafiltration simulations 
 
function memb 
  
    tspan=0:10:300 
    x=[]; 
    y=[]; 
    vols=[]; 
    conc=[]; 
    mass=[]; 
    mass2=[]; 
    pt=[]; 
    purity=[]; 
    yield=[];  
    purity2=[]; 
    yield2=[]; 
    single=[]; 
    single_i=[]; 
    single_j=[]; 
    mm=[]; 
    conc1=[]; 
    conc2=[]; 
    conc3=[]; 
    conc4=[]; 
    nc1=[]; 
    nc3=[]; 
    nm1=[]; 
    nm3=[]; 
    mv1=[]; 
   
        x0=[1.5 0 1 0]; % c1ismall fragments=1.5mol and c1_Hub=1 mol 
        options = odeset('RelTol',1e-5,'AbsTol',1e-7); 
        %AbsTol is x4-x5 in modulus 
        %RelTol is (x5-x4)/x4 in modulus 
  
     [t,x] = ode45(@odetest,tspan,x0,options) 
         
        for i=1:length(tspan) 
            Vf=0.400; %feed tank =0.2L,stage1=0.1L and stage2=0.1L 
            A=0.0014;%m2 
            J= 8;%L/(m2 h bar) 
            p= 20;%bar 
            F1= J*A*p; %L/h 
            rc=0.5; %rc=F3/F1 
            F3= rc*F1; 
            F2= F1-F3; 
            v= (tspan(i)*F2)/Vf; 
            vols= [vols,v]; 
              
             %j=PEG2000, i=PEG400 
             %A(:,n) is the nth column of matrix A.  
             %A(m,:) is the mth row of matrix   
        end 
                
      for a=1:length(vols) 
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                    c1=x(:,1); 
                    conc1=[conc1, c1]; 
                    c2=x(:,2); 
                    conc2=[conc2,c2]; 
                    c3=x(:,3); 
                    conc3=[conc3, c3]; 
                    c4=x(:,4); 
                    conc4=[conc4,c4]; 
                     
                    %normalized concentration                     
                    n1=x(:,1)/x(1,1); 
                    nc1=[nc1, n1]; 
                    n3=x(:,3)/x(1,3); 
                    nc3=[nc3,n3]; 
              
                    %but if we recover the 2nd stage 
                    V1=0.2+0.1;%L feed tank has 100 mL and each 
membrance cell+ tubing is 100 mL  
                    V2=0.1;%L           
                    mm=[ x(:,1)*V1,x(:,2)*V2,x(:,3)*V1,x(:,4)*V2]; 
%mass in grams 
                    mm2=mm(:,3)+ mm(:,4); %m_PEG2000 final 
                    mm1= mm2+ mm(:,2)+ mm(:,1);% m_PEG2000 final+ 
m_PEG400 final 
                     
                    p2= (mm2./ mm1)*100; 
                    purity2=[purity2,p2]; %of PEG2000 
                                
                    y2=(mm2./mm(1,3))*100; 
                    yield2=[yield2,y2]; %of PEG2000 
                     
                    %normalized mass 
                    n_m1=mm(:,1)/mm(1,1); 
                    nm1=[nm1, n_m1]; 
                    n_m3=mm(:,3)/mm(1,3); 
                    nm3=[nm3,n_m3]; 
           end 
             
    figure 
    subplot(1,2,1) 
    plot(vols,c1,'g-*',vols,c3,'y-o') 
    xlabel('vols'); 
    ylabel('Concentration 1st stage (g/L)'); 
    title('1stage profile'); 
    %axis([0 13 0 1]) 
    legend('Cr1-2000','Cr1-8000') 
    %set(gca, 'XLim', [0, 14], 'XTick', 0:2:14,'XTickLabel', 0:2:); 
     
    subplot(1,2,2) 
    plot(vols,c2,'b--<',vols,c4,'r-*') 
    xlabel('vols'); 
    ylabel('Concentration 2nd stage (g/L)'); 
    title('2stage profile') 
    legend('Cr2-2000','Cr2-8000') 
   %set(gca, 'XLim', [0, 14], 'XTick', 0:2:14,'XTickLabel', 0:2:14); 
    
    figure  
    subplot(1,2,1) 
    plot(vols,nc1,'g-*',vols,nc3,'y-o') 
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    xlabel('vols'); 
    ylabel('Normalized Concentration (C/C0)'); 
    title('Normalized_concentrations profile'); 
    legend('Cr1-2000','Cr1-8000') 
    %set(gca, 'XLim', [0, 14], 'XTick', 0:2:14,'XTickLabel', 0:2:14); 
     
    subplot(1,2,2) 
    plot(vols,nm1,'g-*',vols,nm3,'y-o') 
    xlabel('vols'); 
    ylabel('Normalized Mass (M/M0)'); 
    title('Normalized_mass profile'); 
    legend('Mr1-2000','Mr1-8000') 
    %set(gca, 'XLim', [0, 14], 'XTick', 0:2:14,'XTickLabel', 0:2:14); 
     
    figure 
    plot(vols,yield2,'b--<',vols,purity2,'k-o') 
    ylim([40 100]) 
    xlabel('vols'); 
    ylabel('yield and purity (%)'); 
    title('two stage diafiltration') 
    legend('yield','purity') 
    %set(gca, 'XLim', [0, 14], 'XTick', 0:2:14,'XTickLabel', 0:2:14); 
         
   hold off  
end %##############        
      
function dxdt=odetest(tactual,xactual) 
        
            V0=0.200; %feed tank volume in L 
            V1=V0+0.1;%0.100+0.100; % 100 mL feed tank+ 100 mL 
membrane1 
            V2=0.1; 
            A=0.0014;%m2 
            J= 8;%L/(m2 h bar) 
            p= 20;%bar 
            F1= J*A*p; %L/h 
            rc=0.5; %rc=F3/F1 
            F3= rc*F1; 
            F2= F1-F3;%(F1=F2+F3) ; 
             
    R1i=0.7995; %i= PEG2000 small residues need to be washed out  
    R1j=0.9668; %j= PEG8000 Hub 1st coupling needs to be retained by 
the membrane 
    R2i=R1i; 
    R2j=R1j; 
     
    Cri1= xactual(1); %(g/L) 
    Crj1= xactual(3); %(g/L) 
    Cr2i= xactual(2); %(g/L) 
    Cr2j= xactual(4); %(g/L) 
     
    dxdt(1,1)= (1/V1)*(-F1*xactual(1)*(1-R1i)+F3*xactual(2));  
    dxdt(2,1)= (1/V2)*(F1*xactual(1)*(1-R1i)-F2*xactual(2)*(1-R2i)-
F3*xactual(2));  
    dxdt(3,1)= (1/V1)*(-F1*xactual(3)*(1-R1j)+F3*xactual(4));  
    dxdt(4,1)= (1/V2)*(F1*xactual(3)*(1-R1j)-F2*xactual(4)*(1-R2j)-
F3*xactual(4)); 
        
end 
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7.2 The HPLC pump Plum flow Rate versus percentage of pump power 
 
 
 
 
Figure 43. Plum flow Rate vs % of pump power 
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